Top compounds associated with response to RP11-729L2.2


Feature Type Standardized
Nominal ANOVA
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.33 5e-17
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.29 2e-14
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.3 2e-14
mRNA PX-12 CTRPv2 pan-cancer AAC 0.23 4e-14
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.27 6e-13
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.27 3e-12
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 2e-11
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 1e-10
mRNA prima-1 CTRPv2 pan-cancer AAC 0.22 2e-10
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.24 7e-10
Download CSV